JonnyFinlay
@Finlay_Jonny
Followers
708
Following
9K
Media
350
Statuses
8K
Ottimo Pharma https://t.co/sRCYpxFIKB , LockBody Tx ( https://t.co/diICqtMEOn ), Granular Tx ( https://t.co/TjlhIKh3IH ), https://t.co/5ZAeGwZg3E .
Glasgow/Co. Down
Joined August 2012
A phenomenal and exciting day for all of us at https://t.co/fHkKY562ap
ft.com
Boss David Epstein hopes to replicate his success at Seagen after $43bn sale last year
1
0
5
Here is how we know that vaccines do not cause autism. I guess just keep reposting this.
statnews.com
Vaccines do not cause autism. You’ve almost certainly read that before — but often without a full explanation of how we know it to be true. Here's how we know.
28
83
183
We've seen reports that we are investigating a child for 'viewing a social media post'. This is completely false. We're investigating the creation of a fake social media account which has been used to send indecent messages. Full facts 👉 https://t.co/KPlzJvcPkQ
0
2K
5K
😁
0
1
10
Kennedy’s case against mRNA vaccines collapses under his own evidence https://t.co/LO25orzgke via @statnews
statnews.com
“This isn't scientific disagreement. It's either staggering incompetence or willful misrepresentation,” writes infectious disease physician Jake Scott.
13
29
55
The silence of Farage, Habib, Robinson, Lowe and the rest of the cult members is deafening when it is one of their own
353
1K
3K
Thrilled to announce that @medicxi portfolio company Vicebio has entered into an exclusive agreement to be acquired by @sanofi for $1.6B, including an upfront payment of $1.15B 🚀🚀 https://t.co/Do76ebQMSx
0
2
8
What a spectacular achievement! Congratulations to the whole @medicxi team - but most of all to Vanni Mariggi who has tirelessly supported Vicebio from inception to exit. These are the kind of deals that create legendary VCs!
Thrilled to announce that @medicxi portfolio company Vicebio has entered into an exclusive agreement to be acquired by @sanofi for $1.6B, including an upfront payment of $1.15B 🚀🚀 https://t.co/Do76ebQMSx
4
2
18
New Public Enemy album is 🔥🔥🔥 You youngsters wouldn't remember this, but rappers used to have something to say. @MrChuckD @FlavorFlav
6
15
103
Smash the mutants 🦠 to end the pandemic era for humanity — with a single shot for all flu and then coronaviruses, HIV, herpes, malaria, cancer and more! These scourges have evaded effective vaccines because they continuously mutate their outer epitopes to evade our immune
18
49
131
❗Alys Pharmaceuticals filed to begin clinical trials of ALY-301, a first-in-class, mast cell–selective c-Kit inhibitor for cold #urticaria. https://t.co/j9Fv3iuT6f
#DermTwitter
dermatologytimes.com
Alys plans to conduct a phase 1/1b trial assessing the efficacy and safety of the mast cell selective c-Kit inhibitor in the CIndU subtype.
0
2
5
Could not agree more. Life as an academic is not easy at all. Making truly great scientific discoveries is extremely difficult and should be celebrated, but Making a successful drug is one of the toughest things one can ever hope to do in science....
It's true that many incredible biomedical scientists have left academia for biotech/pharma. Their biggest new discoveries may perhaps have been in academia, their biggest drug approvals with an impact on patients' lives have been in industry. The identification of a new
0
0
6
Seconded!
Our 2nd drug to the clinic! this time Alys Pharma is bringing a bispecific Ab directed at c-Kit and CD203c to selectively target pathogenic, activated mast cells. I am so very proud of this team! @Finlay_Jonny @HarrisVitiligo @medicxi. These therapies promise to transform
0
0
3
Our 2nd drug to the clinic! this time Alys Pharma is bringing a bispecific Ab directed at c-Kit and CD203c to selectively target pathogenic, activated mast cells. I am so very proud of this team! @Finlay_Jonny @HarrisVitiligo @medicxi. These therapies promise to transform
3
4
32
Welcome to the world ALY-301. When we designed this molecule we aimed to provide the very first truly mast cell-selective KIT inhibitory bispecific. It's a joy to see that aim fulfilled. Off to the clinic @HarrisVitiligo @itchdoctor @medicxi
1
1
8
@sanofi makes $9.5B acquisition of Blueprint which develops c-Kit blocking Rx. Our company, Alys Pharma has developed next gen Rx for c-Kit blocking with biSAb. This field is 🔥. @medicxi
https://t.co/n9slzHFGzp
ca.finance.yahoo.com
PARIS (Reuters) -France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for up to $9.5 billion to boost its position in rare immunology diseases, in the biggest deal struck by a...
0
3
9
The true goals of Brexit? 1.Make the UK population poorer. 2.Weaken the UK on the international stage. 3.Render the UK irrelevant in global affairs. 4.Avoid EU-wide tax transparency so the British elite could keep hiding their money. Brexit has completely failed. We’re all
129
154
575
We’ve formed the RxBiologics SAB, bringing together leaders in antibody discovery to help guide innovation and strategy. Joining Jonny Finlay are experts from Diagonal Therapeutics, https://t.co/Vp8hdbyJOC, Merck, and Granular Therapeutics. 🔗 Read more: https://t.co/OvPDssxD5N
0
1
0
Wow. This kind of take is growing in frequency - but it’s still a bad take A thread 🧵
Irrespective of one's take on $SMMT and ivonescimab's HR in NSCLC.... The fact that the most valued oncology project today ( $SMMT's market cap is 17.3B even after Friday's crash) is practically a combination of two approved MOAs in lung cancer (Keytruda and Avastin) is very
1
8
33
The British public refuse to accept that it's cheaper to provide welfare than withdraw it. Fewer benefits result in increased crime and poorer public health, requiring increased resources for the police and NHS. Prevention is cheaper than the cure, it's that fucking simple.
88
485
4K